Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals

American Journal of Cardiology

Volumn 110, Issue 8, 2012, Pages 1078-1084

  Pearce, Daniel ^a   Ani, Chizobam ^a,b   Espinosa Silva, Yaminah ^c   Clark, Ryan ^c   Fatima, Khuteja ^c   Rahman, Munira ^c   Diebolt, Erik ^c   Ovbiagele, Bruce ^d  

^a LOMA LINDA UNIVERSITY   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; DRUG ELUTING STENT; ETHNICITY; FEMALE; GENDER; HAZARD; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART CATHETERIZATION; HEMIPLEGIA; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-9; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PARAPLEGIA; PATIENT CARE; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SERODIAGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRATIFIED SAMPLE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; COMORBIDITY; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UNITED STATES;

EID: 84866742323     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.045     Document Type: Article

References (28)

1. K.J. Greenlund, W.H. Giles, N.L. Keenan, A.M. Malarcher, Z.J. Zheng, M.L. Casper, G.W. Heath, J.B. Croft Heart Disease and Stroke Mortality in the 20th Century 2006 Oxford University Press Oxford, United Kingdom
2. A.M. Minino, R.N. Anderson, L.A. Fingerhut, M.A. Boudreault, M. Warner Deaths: injuries 2002 Natl Vital Stat Rep 54 2006 1 124
3. M.T. May, J.A. Sterne, D. Costagliola, C.A. Sabin, A.N. Phillips, A.C. Justice, F. Dabis, J. Gill, J. Lundgren, R.S. Hogg, F. de Wolf, G. Fatkenheuer, S. Staszewski, A. d'Arminio Monforte, M. Egger HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis Lancet 368 2006 451 458
4. C. Smith Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study AIDS 24 2010 1537 1548
5. V.V. Joshi, B. Pawel, E. Conner, L. Sharer, J.M. Oleske, S. Morrison, J. Marin-Garcia Arteriopathy in children with acquired immune deficiency syndrome Pediatr Pathol 7 1987 261 275
6. D. Torre, A. Pugliese Interleukin-18: a proinflammatory cytokine in HIV-1 infection Curr HIV Res 4 2006 423
7. Agency for Healthcare Research and Quality Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP) 1997-2006 Agency for Healthcare Research and Quality Bethesda, Maryland
8. C. Ani, D. Pan, D. Martins, B. Ovbiagele Age- and sex-specific in-hospital mortality after myocardial infarction in routine clinical practice Cardiol Res Pract 2010 2010 752 765
9. M. Charlson, T.P. Szatrowski, J. Peterson, J. Gold Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245 1251
10. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J.C. Luthi, L.D. Saunders, C.A. Beck, T.E. Feasby, W.A. Ghali Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139
11. M. Battegay, L. Elzi Morbidity and mortality in HIV-infected individuals - a shift towards comorbidities Swiss Med Wkly 139 2009 564 570
12. S. Matetzky, M. Domingo, S. Kar, M. Noc, P.K. Shah, S. Kaul, E. Daar, B. Cercek Acute myocardial infarction in human immunodeficiency virus-infected patients Arch Intern Med 163 2003 457 460
13. T.S. Sharma, S. Messiah, S. Fisher, T.L. Miller, S.E. Lipshultz Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus J Cardiometab Syndr 3 2008 93 97
14. V.A. Triant, H. Lee, C. Hadigan, S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506 2512
15. F. Boccara Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors AIDS 22 suppl 2008 S19 S26
16. S.W. Worm, C. Sabin, R. Weber, P. Reiss, W. El-Sadr, F. Dabis, S. De Wit, M. Law, A.D. Monforte, N. Friis-Moller, O. Kirk, E. Fontas, I. Weller, A. Phillips, J. Lundgren Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study J Infect Dis 201 2010 318 330
17. H. Zhou, W.M. Pandak Jr, V. Lyall, R. Natarajan, P.B. Hylemon HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease Mol Pharmacol 68 2005 690 700
18. P. Paton, A. Tabib, R. Loire, R. Tete Coronary artery lesions and human immunodeficiency virus infection Res Virol 144 1993 225 231
19. L. Guillevin Vasculitides in the context of HIV infection AIDS 22 suppl 2008 S27 S33
20. M. Shahmanesh, S. Das, M. Stolinski, F. Shojaee-Moradie, N.C. Jackson, W. Jefferson, R. Cramb, P. Nightingale, A.M. Umpleby Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia J Clin Endocrinol Metab 90 2005 755 760
21. T.H. Burdo, J. Lo, S. Abbara, J. Wei, M.E. DeLelys, F. Preffer, E.S. Rosenberg, K.C. Williams, S. Grinspoon Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients J Infect Dis 204 2011 1227 1236
22. J.E. Burkhalter, C.M. Springer, R. Chhabra, J.S. Ostroff, B.D. Rapkin Tobacco use and readiness to quit smoking in low-income HIV-infected persons Nicotine Tob Res 7 2005 511
23. A. Carr, K. Samaras, A. Thorisdottir, G.R. Kaufmann, D.J. Chisholm, D.A. Cooper Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study Lancet 353 1999 2093 2099
24. J.W. Carey, R. Mejia, T. Bingham, C. Ciesielski, D. Gelaude, J.H. Herbst, M. Sinunu, E. Sey, N. Prachand, R.A. Jenkins, R. Stall Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles AIDS Behav 13 2009 1084 1096
25. A.J. Lansky, J.S. Hochman, P.A. Ward, G.S. Mintz, R. Fabunmi, P.B. Berger, G. New, C.L. Grines, C.G. Pietras, M.J. Kern, M. Ferrell, M.B. Leon, R. Mehran, C. White, J.H. Mieres, J.W. Moses, G.W. Stone, A.K. Jacobs Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association Circulation 111 2005 940 953
26. H. Masoomi, S.D. Mills, M.O. Dolich, P. Dang, J.C. Carmichael, N.T. Nguyen, M.J. Stamos Outcomes of laparoscopic and open appendectomy for acute appendicitis in patients with acquired immunodeficiency syndrome Am Surg 77 2011 1372 1376
27. C.A. Morrison, M.M. Wyatt, M.M. Carrick Effects of human immunodeficiency virus status on trauma outcomes: a review of the national trauma database Surg Infect 11 2010 41 47
28. K. McDavid Harrison, Q. Ling, R. Song, H.I. Hall County-level socioeconomic status and survival after HIV diagnosis, United States Ann Epidemiol 18 2008 919 927